A team led by researchers at the Massachusetts Institute of Technology and Harvard Medical School have developed a synthetic biomarker assay that they say could improve early detection and monitoring of a variety of diseases.

In particular, the approach, which uses immunoassays run on inexpensive paper test strips as its read-out, could prove valuable in point-of-care and resource-constrained settings, Andrew Warren, an MIT researcher and one of the developers of the method, told ProteoMonitor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.